Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
1.
Braz. j. med. biol. res ; 35(9): 1069-1074, Sept. 2002. tab, graf
Article Dans Anglais | LILACS | ID: lil-325902

Résumé

Losartan, an AT1 angiotensin II (ANG II) receptor non-peptide antagonist, induces an increase in mean arterial pressure (MAP) when injected intracerebroventricularly (icv) into rats. The present study investigated possible effector mechanisms of the increase in MAP induced by icv losartan in unanesthetized rats. Male Holtzman rats (280-300 g, N = 6/group) with a cannula implanted into the anterior ventral third ventricle received an icv injection of losartan (90 æg/2 æl) that induced a typical peak pressor response within 5 min. In one group of animals, this response to icv losartan was completely reduced from 18 ± 1 to 4 ± 2 mmHg by intravenous (iv) injection of losartan (2.5-10 mg/kg), and in another group, it was partially reduced from 18 ± 3 to 11 ± 2 mmHg by iv prazosin (0.1-1.0 mg/kg), an alpha1-adrenergic antagonist (P<0.05). Captopril (10 mg/kg), a converting enzyme inhibitor, injected iv in a third group inhibited the pressor response to icv losartan from 24 ± 3 to 7 ± 2 mmHg (P<0.05). Propranolol (10 mg/kg), a ß-adrenoceptor antagonist, injected iv in a fourth group did not alter the pressor response to icv losartan. Plasma renin activity and serum angiotensin-converting enzyme activity were not altered by icv losartan in other animals. The results suggest that the pressor effect of icv losartan depends on angiotensinergic and alpha1-adrenoceptor activation, but not on increased circulating ANG II


Sujets)
Animaux , Mâle , Rats , Agonistes alpha-adrénergiques , Inhibiteurs de l'enzyme de conversion de l'angiotensine , Hypertension artérielle , Losartan , Peptidyl-Dipeptidase A , Récepteurs aux angiotensines , Rénine , Captopril , Injections ventriculaires , Losartan , Prazosine , Propranolol , Dosage radioimmunologique , Rat Sprague-Dawley
2.
Braz. j. med. biol. res ; 34(9): 1185-1190, Sept. 2001. graf
Article Dans Anglais | LILACS | ID: lil-290395

Résumé

Non-adrenergic ligands that bind to imidazoline receptors (I-R), a selective ligand that binds to alpha2-adrenoceptors (alpha2-AR) and mixed ligands that bind to both receptors were tested for their action on water intake behavior of 24-h water-deprived rats. All drugs were injected into the third cerebral ventricle. Except for agmatine (80 nmol), mixed ligands binding to I-R/alpha2-AR such as guanabenz (40 nmol) and UK 14304 (20 nmol) inhibited water intake by 65 percent and up to 95 percent, respectively. The selective non-imidazoline alpha2-AR agonist, alpha-methylnoradrenaline, produced inhibition of water intake similar to that obtained with guanabenz, but at higher doses (80 nmol). The non-adrenergic I-R ligands histamine (160 nmol, mixed histaminergic and imidazoline ligand) and imidazole-4-acetic acid (80 nmol, imidazoline ligand) did not alter water intake. The results show that selective, non-imidazoline alpha2-AR activation suppresses water intake, and suggest that the action on imidazoline sites by non-adrenergic ligands is not sufficient to inhibit water intake


Sujets)
Animaux , Mâle , Rats , Consommation de boisson/effets des médicaments et des substances chimiques , Guanidines/pharmacologie , Imidazoles/pharmacologie , alpha-Méthyl-noradrénaline/pharmacologie , Quinoxalines/pharmacologie , Récepteurs alpha-2 adrénergiques/physiologie , Imidazoles/agonistes , Injections ventriculaires , Ligands , Rat Sprague-Dawley , Vasoconstricteurs/pharmacologie , Privation hydrique
SÉLECTION CITATIONS
Détails de la recherche